 |
PDBsum entry 2r27
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
2r27
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Oxidoreductase
|
 |
|
Title:
|
 |
Constitutively zinc-deficient mutant of human superoxide dismutase (sod), c6a, h80s, h83s, c111s
|
|
Structure:
|
 |
Superoxide dismutase [cu-zn]. Chain: a, b. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: sod1. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
2.00Å
|
R-factor:
|
0.184
|
R-free:
|
0.246
|
|
|
Authors:
|
 |
B.R.Roberts,E.D.Getzoff,P.A.Karplus,J.S.Beckman,J.A.Tainer
|
Key ref:
|
 |
B.R.Roberts
et al.
(2007).
Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS.
J Mol Biol,
373,
877-890.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
24-Aug-07
|
Release date:
|
11-Dec-07
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P00441
(SODC_HUMAN) -
Superoxide dismutase [Cu-Zn] from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
154 a.a.
134 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 4 residue positions (black
crosses)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.15.1.1
- superoxide dismutase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
2 superoxide + 2 H+ = H2O2 + O2
|
 |
 |
 |
 |
 |
2
×
superoxide
|
+
|
2
×
H(+)
|
=
|
H2O2
|
+
|
O2
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Fe cation or Mn(2+) or (Zn(2+) and Cu cation)
|
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Mol Biol
373:877-890
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS.
|
|
B.R.Roberts,
J.A.Tainer,
E.D.Getzoff,
D.A.Malencik,
S.R.Anderson,
V.C.Bomben,
K.R.Meyers,
P.A.Karplus,
J.S.Beckman.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Over 130 mutations to copper, zinc superoxide dismutase (SOD) are implicated in
the selective death of motor neurons found in 25% of patients with familial
amyotrophic lateral sclerosis (ALS). Despite their widespread distribution, ALS
mutations appear positioned to cause structural and misfolding defects. Such
defects decrease SOD's affinity for zinc, and loss of zinc from SOD is
sufficient to induce apoptosis in motor neurons in vitro. To examine the
importance of the zinc site in the structure and pathogenesis of human SOD, we
determined the 2.0-A-resolution crystal structure of a designed zinc-deficient
human SOD, in which two zinc-binding ligands have been mutated to
hydrogen-bonding serine residues. This structure revealed a 9 degrees twist of
the subunits, which opens the SOD dimer interface and represents the largest
intersubunit rotational shift observed for a human SOD variant. Furthermore, the
electrostatic loop and zinc-binding subloop were partly disordered, the
catalytically important Arg143 was rotated away from the active site, and the
normally rigid intramolecular Cys57-Cys146 disulfide bridge assumed two
conformations. Together, these changes allow small molecules greater access to
the catalytic copper, consistent with the observed increased redox activity of
zinc-deficient SOD. Moreover, the dimer interface is weakened and the
Cys57-Cys146 disulfide is more labile, as demonstrated by the increased
aggregation of zinc-deficient SOD in the presence of a thiol reductant. However,
equimolar Cu,Zn SOD rapidly forms heterodimers with zinc-deficient SOD (t1/2
approximately 15 min) and prevents aggregation. The stabilization of
zinc-deficient SOD as a heterodimer with Cu,Zn SOD may contribute to the
dominant inheritance of ALS mutations. These results have general implications
for the importance of framework stability on normal metalloenzyme function and
specific implications for the role of zinc ion in the fatal neuropathology
associated with SOD mutations.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Key structural features of wild-type Cu,Zn SOD. (a)
In the right-hand subunit (chain A), copper (orange) and zinc
(grey) are shown as spheres. Loop IV is divided into three
sections: the dimerization subloop (residues 50–54, yellow)
creates part of the dimer interface, the disulfide subloop
(residues 55–61, raspberry) covalently attaches to the
β-barrel via the Cys57–Cys146 disulfide, and the zinc-binding
region (residues 62–83, blue) contains His63, His71, His80,
and Asp83 (shown as sticks). Copper is coordinated by residues
His63, His46, His48, and His120 (orange sticks). (b) Surface
buried upon dimerization is shown for chain A. The vert,
similar 1400-Å^2 area is divided into three regions: the
area contributed by the dimerization subloop (yellow), the area
buried by the interaction with the dimerization subloop of chain
B (cyan with yellow ribbon showing chain B segment), and the
area from the β-barrel interaction (light grey). The
dimerization subloop is involved in vert,
similar 75% of the total surface area buried by the dimer.
|
 |
Figure 3.
Fig. 3. Increased copper accessibility in zinc-deficient SOD.
(a) Access to the active-site copper (orange) of wild-type Cu,Zn
SOD (green) is limited by the electrostatic and zinc-binding
loops. The red dashes illustrate the dimensions of the
active-site channel, which narrows from vert,
similar 12 Å to vert,
similar 4 Å. (b) The active site of zinc-deficient SOD
(blue) is more open and accessible due to the disorder of the
electrostatic and zinc-binding loops. Although the disordered
residues in these loops may transiently restrict the active-site
channel, their flexibility allows small molecules greater access
to the copper.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Elsevier:
J Mol Biol
(2007,
373,
877-890)
copyright 2007.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Del Grande,
M.Luigetti,
A.Conte,
I.Mancuso,
S.Lattante,
G.Marangi,
G.Stipa,
M.Zollino,
and
M.Sabatelli
(2011).
A novel L67P SOD1 mutation in an Italian ALS patient.
|
| |
Amyotroph Lateral Scler,
12,
150-152.
|
 |
|
|
|
|
 |
R.Ballestín,
A.Molowny,
M.P.Marín,
G.Esteban-Pretel,
A.M.Romero,
C.Lopez-Garcia,
J.Renau-Piqueras,
and
X.Ponsoda
(2011).
Ethanol reduces zincosome formation in cultured astrocytes.
|
| |
Alcohol Alcohol,
46,
17-25.
|
 |
|
|
|
|
 |
C.Huang,
P.Y.Xia,
and
H.Zhou
(2010).
Sustained expression of TDP-43 and FUS in motor neurons in rodent's lifetime.
|
| |
Int J Biol Sci,
6,
396-406.
|
 |
|
|
|
|
 |
F.Palacios,
G.Cota,
S.Horjales,
A.Lima,
J.Battistoni,
J.Sotelo-Silveira,
and
M.Marín
(2010).
An antibody-based affinity chromatography tool to assess Cu, Zn superoxide dismutase (SOD) G93A structural complexity in vivo.
|
| |
Biotechnol J,
5,
328-334.
|
 |
|
|
|
|
 |
J.R.Auclair,
K.J.Boggio,
G.A.Petsko,
D.Ringe,
and
J.N.Agar
(2010).
Strategies for stabilizing superoxide dismutase (SOD1), the protein destabilized in the most common form of familial amyotrophic lateral sclerosis.
|
| |
Proc Natl Acad Sci U S A,
107,
21394-21399.
|
 |
|
|
|
|
 |
J.Yin,
S.Hu,
W.Jiang,
L.Liu,
S.Lan,
X.Song,
and
C.Liu
(2010).
DNA-triggered aggregation of copper, zinc superoxide dismutase in the presence of ascorbate.
|
| |
PLoS One,
5,
e12328.
|
 |
|
|
|
|
 |
M.Nassif,
S.Matus,
K.Castillo,
and
C.Hetz
(2010).
Amyotrophic lateral sclerosis pathogenesis: a journey through the secretory pathway.
|
| |
Antioxid Redox Signal,
13,
1955-1989.
|
 |
|
|
|
|
 |
R.Stifanese,
M.Averna,
R.De Tullio,
M.Pedrazzi,
F.Beccaria,
F.Salamino,
M.Milanese,
G.Bonanno,
S.Pontremoli,
and
E.Melloni
(2010).
Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis.
|
| |
J Biol Chem,
285,
631-643.
|
 |
|
|
|
|
 |
A.Nordlund,
L.Leinartaite,
K.Saraboji,
C.Aisenbrey,
G.Gröbner,
P.Zetterström,
J.Danielsson,
D.T.Logan,
and
M.Oliveberg
(2009).
Functional features cause misfolding of the ALS-provoking enzyme SOD1.
|
| |
Proc Natl Acad Sci U S A,
106,
9667-9672.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Tiwari,
A.Liba,
S.H.Sohn,
S.V.Seetharaman,
O.Bilsel,
C.R.Matthews,
P.J.Hart,
J.S.Valentine,
and
L.J.Hayward
(2009).
Metal deficiency increases aberrant hydrophobicity of mutant superoxide dismutases that cause amyotrophic lateral sclerosis.
|
| |
J Biol Chem,
284,
27746-27758.
|
 |
|
|
|
|
 |
B.K.Bitanihirwe,
and
M.G.Cunningham
(2009).
Zinc: the brain's dark horse.
|
| |
Synapse,
63,
1029-1049.
|
 |
|
|
|
|
 |
J.J.Perry,
A.S.Hearn,
D.E.Cabelli,
H.S.Nick,
J.A.Tainer,
and
D.N.Silverman
(2009).
Contribution of human manganese superoxide dismutase tyrosine 34 to structure and catalysis.
|
| |
Biochemistry,
48,
3417-3424.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.M.Leitch,
L.T.Jensen,
S.D.Bouldin,
C.E.Outten,
P.J.Hart,
and
V.C.Culotta
(2009).
Activation of Cu,Zn-superoxide dismutase in the absence of oxygen and the copper chaperone CCS.
|
| |
J Biol Chem,
284,
21863-21871.
|
 |
|
|
|
|
 |
K.S.Molnar,
N.M.Karabacak,
J.L.Johnson,
Q.Wang,
A.Tiwari,
L.J.Hayward,
S.J.Coales,
Y.Hamuro,
and
J.N.Agar
(2009).
A common property of amyotrophic lateral sclerosis-associated variants: destabilization of the copper/zinc superoxide dismutase electrostatic loop.
|
| |
J Biol Chem,
284,
30965-30973.
|
 |
|
|
|
|
 |
L.Miao,
and
D.K.St Clair
(2009).
Regulation of superoxide dismutase genes: implications in disease.
|
| |
Free Radic Biol Med,
47,
344-356.
|
 |
|
|
|
|
 |
M.G.Bonini,
S.A.Gabel,
K.Ranguelova,
K.Stadler,
E.F.Derose,
R.E.London,
and
R.P.Mason
(2009).
Direct magnetic resonance evidence for peroxymonocarbonate involvement in the cu,zn-superoxide dismutase peroxidase catalytic cycle.
|
| |
J Biol Chem,
284,
14618-14627.
|
 |
|
|
|
|
 |
V.Balasubramanian,
M.Ezhevskaya,
H.Moons,
M.Neuburger,
C.Cristescu,
S.Van Doorslaer,
and
C.Palivan
(2009).
Structural characterization of a highly active superoxide-dismutase mimic.
|
| |
Phys Chem Chem Phys,
11,
6778-6787.
|
 |
|
|
|
|
 |
A.Nordlund,
and
M.Oliveberg
(2008).
SOD1-associated ALS: a promising system for elucidating the origin of protein-misfolding disease.
|
| |
HFSP J,
2,
354-364.
|
 |
|
|
|
|
 |
C.Kayatekin,
J.A.Zitzewitz,
and
C.R.Matthews
(2008).
Zinc binding modulates the entire folding free energy surface of human Cu,Zn superoxide dismutase.
|
| |
J Mol Biol,
384,
540-555.
|
 |
|
|
|
|
 |
D.Brambilla,
C.Mancuso,
M.R.Scuderi,
P.Bosco,
G.Cantarella,
L.Lempereur,
G.Di Benedetto,
S.Pezzino,
and
R.Bernardini
(2008).
The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: a point of view for an assessment of the risk/benefit profile.
|
| |
Nutr J,
7,
29.
|
 |
|
|
|
|
 |
Q.Wang,
J.L.Johnson,
N.Y.Agar,
and
J.N.Agar
(2008).
Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.
|
| |
PLoS Biol,
6,
e170.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |